Ann: Pipeline Collaboration for Next Generation Formulations, page-20

Strong buy signal today? I suspect the result for ovarian cancer trial may be out soon, hopefully to see a market re-rate since by then all the three phase 1b trial results for PTX 200 are out.

Next news shall be the trial plan for PTX 100, hopefully to be announced in Nov/Dec 2018.

And followed by PTX 200 phase 2 result in Q1 2019 for breast cancer.

Maybe someone here can go to Bistron's thread and blow the horn. poo...poo...poo...PTX for another multi-bagger within next 12 months.